Literature DB >> 24990878

Determinants of breast cancer progression.

Li Ma1.   

Abstract

New therapeutic opportunities may arise as a result of discovering the determinants of breast cancer progression.
Copyright © 2014, American Association for the Advancement of Science.

Entities:  

Mesh：

Year:  2014        PMID： 24990878      PMCID： PMC4157363          DOI： 10.1126/scitranslmed.3009587

Source DB:  PubMed          Journal:  Sci Transl Med        ISSN： 1946-6234            Impact factor:   17.956


  10 in total

Review 1.  Deubiquitinating enzymes as novel anticancer targets.

Authors:  Benjamin Nicholson; Jeffrey G Marblestone; Tauseef R Butt; Michael R Mattern
Journal:  Future Oncol       Date:  2007-04       Impact factor: 3.404

Review 2.  The Hippo pathway: regulators and regulations.

Authors:  Fa-Xing Yu; Kun-Liang Guan
Journal:  Genes Dev       Date:  2013-02-15       Impact factor: 11.361

Review 3.  The functions and regulation of the PTEN tumour suppressor.

Authors:  Min Sup Song; Leonardo Salmena; Pier Paolo Pandolfi
Journal:  Nat Rev Mol Cell Biol       Date:  2012-04-04       Impact factor: 94.444

Review 4.  Non-coding RNAs as regulators of mammary development and breast cancer.

Authors:  Hai-Long Piao; Li Ma
Journal:  J Mammary Gland Biol Neoplasia       Date:  2012-02-17       Impact factor: 2.673

5.  miR-9, a MYC/MYCN-activated microRNA, regulates E-cadherin and cancer metastasis.

Authors:  Li Ma; Jennifer Young; Harsha Prabhala; Elizabeth Pan; Pieter Mestdagh; Daniel Muth; Julie Teruya-Feldstein; Ferenc Reinhardt; Tamer T Onder; Scott Valastyan; Frank Westermann; Frank Speleman; Jo Vandesompele; Robert A Weinberg
Journal:  Nat Cell Biol       Date:  2010-02-21       Impact factor: 28.824

6.  Therapeutic silencing of miR-10b inhibits metastasis in a mouse mammary tumor model.

Authors:  Li Ma; Ferenc Reinhardt; Elizabeth Pan; Jürgen Soutschek; Balkrishen Bhat; Eric G Marcusson; Julie Teruya-Feldstein; George W Bell; Robert A Weinberg
Journal:  Nat Biotechnol       Date:  2010-03-28       Impact factor: 54.908

7.  Tumour invasion and metastasis initiated by microRNA-10b in breast cancer.

Authors:  Li Ma; Julie Teruya-Feldstein; Robert A Weinberg
Journal:  Nature       Date:  2007-09-26       Impact factor: 49.962

8.  LIFR is a breast cancer metastasis suppressor upstream of the Hippo-YAP pathway and a prognostic marker.

Authors:  Dahu Chen; Yutong Sun; Yongkun Wei; Peijing Zhang; Abdol Hossein Rezaeian; Julie Teruya-Feldstein; Sumeet Gupta; Han Liang; Hui-Kuan Lin; Mien-Chie Hung; Li Ma
Journal:  Nat Med       Date:  2012-09-23       Impact factor: 53.440

9.  Regulation of the Hippo-YAP pathway by G-protein-coupled receptor signaling.

Authors:  Fa-Xing Yu; Bin Zhao; Nattapon Panupinthu; Jenna L Jewell; Ian Lian; Lloyd H Wang; Jiagang Zhao; Haixin Yuan; Karen Tumaneng; Hairi Li; Xiang-Dong Fu; Gordon B Mills; Kun-Liang Guan
Journal:  Cell       Date:  2012-08-02       Impact factor: 41.582

10.  Deubiquitylation and stabilization of PTEN by USP13.

Authors:  Peijing Zhang; Yongkun Wei; Jinsong Zhang; Hai-Long Piao; Wenqi Wang; Subbareddy Maddika; Min Wang; Dahu Chen; Yutong Sun; Mien-Chie Hung; Junjie Chen; Li Ma
Journal:  Nat Cell Biol       Date:  2013-11-24       Impact factor: 28.824
  10 in total
  1 in total

1.  Hypoxia-induced lncRNA RBM5-AS1 promotes tumorigenesis via activating Wnt/β-catenin signaling in breast cancer.

Authors:  Xinping Li; Jingyan Yang; Ruiqi Ni; Jintian Chen; Yanhao Zhou; Hao Song; Liang Jin; Yi Pan
Journal:  Cell Death Dis       Date:  2022-02-02       Impact factor: 8.469
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.